pioneers in diabetes commercialization strategy · diagnostics and monitoring y global assessment...
TRANSCRIPT
Founded in 1992, Health Advances is a leading healthcare strategy firm
advising clients in the diagnostic, device, therapeutic, and biotech sectors.
Healthcare executives rely on our professionals to help them make confident
decisions involving the greatest challenges in the commercialization of
medical technologies.
Contact: Sheela [email protected]
BostonSan FranciscoWashington DCZurich
781-647-3435
www.healthadvances.com
www.healthadvances.com/diabetes
Pioneers inDiabetes
CommercializationStrategy
Core Competencies
y Corporate Strategy
y Health Economic Analysis
y Market Assessment
y Portfolio Planning
y Pricing and Reimbursement
y Product Positioning
y Sales and Marketing Strategy
y Transaction Due Diligence
Experience. It’s What Sets Us Apart.
Operating at the intersection of science, technology, and business strategy, Health Advances provides clients with
innovative solutions based on deep industry insight, analytical rigor, and an objective perspective. Example projects include:
Diagnostics and Monitoring
y Global assessment of continuous
glucose monitoring (CGM) market
y Commercial assessment of existing
and future diabetes biomarkers
y Global corporate strategy for
traditional glucose monitoring market
y Reimbursement and pricing strategy
for retinopathy imaging diagnostic
y Commercial plan for non-invasive
glucose monitoring system
y US sales forecast for innovative
inpatient CGM system
y Competitive assessment of novel
glucose monitoring platform
Therapeutics (Non-Insulin)
y Global product positioning
strategy for DPP-IV inhibitor
y Market assessment for beta
cell regeneration technologies
y Product lifecycle strategy for TZD
(thiazolidinedione) product line
y Transaction diligence for an
innovative GLP-1 product
y Go-to-market plan for a novel
immune-based therapy
y Clinical trial strategy for disease-
modifying agent in type 1 diabetes
y Screening assessment of siRNA
technology for diabetic indications
Insulin/Insulin Delivery
y Single-use insulin pump customer
analysis and product positioning
y Global insulin market model
and lifecycle strategy
y Commercial plan for innovative
insulin delivery system
y Monetization path for company
with glucose-responsive insulin
y Acquisition diligence on first-in-class
insulin patch pump
y Partnership strategy support
for insulin device development
y Pricing and reimbursement strategy
for novel insulin pump
Complications
y Pipeline assessment for micro-
and macro-vascular complications
y Global sales forecast for
resistant hypertension therapy
y Indication prioritization for neuropathic
pain development candidate
y Specialty profiling and asset
review for gastroparesis
y Renal franchise growth strategy
with diabetes segmentation
y Commercial assessment of RAGE
and related novel targets
y Development plan to repurpose
an agent for macular edema
www.healthadvances.com/diabetes